December 4, 2018

Integral Molecular’s Therapeutic MAbs Against CB1 to Treat NASH Enter New Development Phase Following $1.4M NIH Award

PHILADELPHIA–(PR NEWSWIRE)–Integral Molecular, the industry leader in antibody discovery against multipass membrane proteins, was awarded $1.4M by the NIH to develop its lead antibodies against cannabinoid […]
November 1, 2018

Integral Molecular Awarded NIH Grant to Discover Neuroimmune Drug Targets in Alzheimer’s Disease

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, the industry leader in membrane protein technologies, was awarded a Small Business Innovation Research (SBIR) grant from the NIH to initiate a target […]
September 18, 2018

Integral Molecular Partners with Merus to Discover Novel Therapeutic Monoclonal Antibodies

PHILADELPHIA – (BUSINESS WIRE) – Integral Molecular, the industry leader in the discovery of monoclonal antibodies (MAbs) against membrane proteins, and Merus N.V. (Nasdaq:MRUS), a clinical-stage […]
June 1, 2018

Integral Molecular Celebrates Epitope Mapping Milestone of 1,000 Epitopes

PHILADELPHIA – (BUSINESS WIRE) -Integral Molecular, the industry leader in the discovery and characterization of antibodies against membrane proteins, celebrates a milestone of mapping 1,000 epitopes […]
May 30, 2018

Integral Molecular’s MPS Antibody Discovery Platform Yields Therapeutic Assets for Oncology and Metabolic Syndrome

Integral Molecular, the industry leader in membrane protein antibody discovery, announces the development of antibody assets targeting membrane proteins important in oncology (Claudin 6) and metabolic […]
March 13, 2018

Integral Molecular’s Protein Engineering Technology Facilitates HIV Vaccine Development

PHILADELPHIA – (BUSINESS WIRE) -Integral Molecular, the industry leader in engineering membrane proteins, has extended its protein engineering capabilities to stabilize viral proteins and produce more […]
December 21, 2017

Integral Molecular expands its epitope mapping platform to identify small molecule binding sites on multipass membrane proteins

PHILADELPHIA–(BUSINESS WIRE)– Integral Molecular, the industry leader in the expression and characterization of multipass membrane proteins, has expanded its mapping capabilities to include small molecules. This […]
September 6, 2017

Integral Molecular hosts Art of Science Residency

PHILADELPHIA (September 6, 2017) – A new kind of interdisciplinary artistic collaboration is happening in Philadelphia this fall. The University City Science Center has partnered with […]
August 30, 2017

Integral Molecular Doubles Antibody Discovery Capacity

PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, a Philadelphia based biotechnology company, announces the expansion of its facility, personnel, and resources dedicated to antibody discovery for membrane protein targets. The […]